Application Nr Approved Date Route Status External Links
ANDA091224 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pregabalin Capsules Are Indicated For: Management Of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Management Of Postherpetic Neuralgia Adjunctive Therapy For The Treatment Of Partial-Onset Seizures In Patients 17 Years Of Age And Older Management Of Fibromyalgia Management Of Neuropathic Pain Associated With Spinal Cord Injury Pediatric Use Information Is Approved For Pfizer’s Lyrica ® (Pregabalin) Capsules And Oral Solution Products. However, Due To Pfizer’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information. Pregabalin Is Indicated For: Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (Dpn) ( 1 ) Postherpetic Neuralgia (Phn) ( 1 ) Adjunctive Therapy For The Treatment Of Partial-Onset Seizures In Patients 17 Years Of Age And Older ( 1 ) Fibromyalgia ( 1 ) Neuropathic Pain Associated With Spinal Cord Injury ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pregabalin PREGABALIN ZINC5152

Comments